Glaukos Corp
NYSE:GKOS

Watchlist Manager
Glaukos Corp Logo
Glaukos Corp
NYSE:GKOS
Watchlist
Price: 138.62 USD -3.23% Market Closed
Market Cap: 7.6B USD
Have any thoughts about
Glaukos Corp?
Write Note

Glaukos Corp
Accrued Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Glaukos Corp
Accrued Liabilities Peer Comparison

Comparables:
BDX
BSX
SYK
ABT
ISRG

Competitive Accrued Liabilities Analysis
Latest Figures & CAGR of Competitors

Company Accrued Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
Glaukos Corp
NYSE:GKOS
Accrued Liabilities
$60.6m
CAGR 3-Years
3%
CAGR 5-Years
16%
CAGR 10-Years
36%
Becton Dickinson and Co
NYSE:BDX
Accrued Liabilities
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Boston Scientific Corp
NYSE:BSX
Accrued Liabilities
$2.3B
CAGR 3-Years
4%
CAGR 5-Years
7%
CAGR 10-Years
7%
Stryker Corp
NYSE:SYK
Accrued Liabilities
$3.5B
CAGR 3-Years
6%
CAGR 5-Years
7%
CAGR 10-Years
3%
Abbott Laboratories
NYSE:ABT
Accrued Liabilities
$6.5B
CAGR 3-Years
-1%
CAGR 5-Years
4%
CAGR 10-Years
6%
Intuitive Surgical Inc
NASDAQ:ISRG
Accrued Liabilities
$867.5m
CAGR 3-Years
21%
CAGR 5-Years
13%
CAGR 10-Years
15%

See Also

What is Glaukos Corp's Accrued Liabilities?
Accrued Liabilities
60.6m USD

Based on the financial report for Sep 30, 2024, Glaukos Corp's Accrued Liabilities amounts to 60.6m USD.

What is Glaukos Corp's Accrued Liabilities growth rate?
Accrued Liabilities CAGR 10Y
36%

Over the last year, the Accrued Liabilities growth was 7%. The average annual Accrued Liabilities growth rates for Glaukos Corp have been 3% over the past three years , 16% over the past five years , and 36% over the past ten years .

Back to Top